Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
44.50    0.00 (0.00%)
Bid:
44.00
Ask:
45.00
Spread: 1.00 (2.273%)
Market Cap: £81.54m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

H1 Update

16 Jul 2024 07:00

RNS Number : 4858W
Iofina PLC
16 July 2024
 

16 July 2024

 

Iofina plc

("Iofina", the "Company" or the "Group")

(AIM: IOF)

 

H1 2024 Corporate Update

14.3% Increase in Crystalline Iodine Produced v H1 2023

IO#10 on Track for Q3 2024

Iodine Prices Remain Strong

 

Iofina plc, specialists in the exploration and production of iodine and manufacturers of specialty chemical products, today provides a brief update to the market regarding its activities during H1 2024 (the "Period").

 

The Company continued to perform as expected during the Period, with Iofina Resources producing 276.1 metric tonnes ("MT") of crystalline iodine from its six IOsorb® iodine plants in Oklahoma as output is traditionally lower in the first half of the year due to less favourable weather conditions. The Company did experience an increase of 14.3% on H1 2023 (241.5 MT) and was within the Company's target range of crystalline iodine production.

 

The Company was able to bring longer-term brine supply stability, with multi-year agreements for the supply of iodide-rich water to two of Iofina Resources' current IOsorb® plants in the Period, enabling consistent iodine production at both plants. Iofina is now working with this partner to potentially bring additional brine to these plants.

 

Iofina's latest build, IO#10 continues to progress well and is on track to be operational in the latter part of Q3 2024. IO#10 is expected to make a material contribution to crystalline iodine production in the second half of the year, with the capacity to produce 100-150MT per annum.

 

Negotiations with the Company's preferred partner for IO#11 are advancing well, with the current aim of commencing the new plant's foundation work before the end of 2024.

 

Based on current production levels and the addition of IO#10 in Q3 2024, the Company anticipates production in the second half of 2024 to be in the range of 355 MT - 380 MT. The total production for 2024 will be dependent on both the start-up date and the rate of ramp-up for IO#10.

 

Demand for Iofina's iodine remained strong throughout the Period and was supported by the customer base. The Company's sales channels remain robust in the current economic market with crystalline iodine, iodine derivatives and non-iodine derivatives products all performing in line with the Board's expectations. The iodine spot price has remained steady in the mid-sixties USD per kg and current indications are that prices are likely to modestly rise in H2 2024, with present iodine demand exceeding supply.

Commenting, President and CEO, Dr. Tom Becker, stated:

"The management team has been focused throughout the period on delivering the planned step-change in growth, so we are pleased that IO#10 remains on track to be switched on in the third quarter, whilst also advancing negotiations with our preferred partner for IO#11.

 

"At the same time, we have been working to ensure consistent output from our existing plants, with production up 14.3% in the first half compared to the same period last year. Additionally, we are working with multiple partners on projects to possibly improve brine supply at several existing plants.

 

"By executing our growth plans combined with the encouraging news in the expected strength in iodine prices, we are excited by the outlook for the rest of the year."

 

Enquiries:

 

Dr. Tom Becker

CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

 

Nomad & Broker:

Henry Fitzgerald-O'Connor/Harry Rees

Canaccord Genuity Limited

Tel: +44 (0)20 7523 8000

 

Media Contact:

Charles Goodwin/Shivantha Thambirajah/Zara McKinlay

Yellow Jersey PR Limited

Tel: +44 (0)7747 788 221/+44 (0)7983 521 488

About Iofina:

Iofina plc (AIM: IOF) is a vertically integrated company that specialises in the production of Iodine and the manufacturing of specialty chemical products. Iofina is the second largest producer of iodine in North America and operates the manufacturing entities Iofina Resources and Iofina Chemical.

LEI: 213800QDMFYVRJYYTQ84

ISIN: GB00B2QL5C79

 

Iofina Resources

Iofina Resources develops, builds, owns, and operates iodine extraction plants using Iofina's WET® IOsorb® technology. Iofina currently operates five producing IOsorb® plants in Oklahoma and is consistently using technology and innovation to improve and expand its operations.

 

Iofina Chemical

Iofina Chemical has manufactured high quality halogen speciality chemicals derived from raw iodine, as well as non-iodine-based products. Iofina Chemical celebrated its 40th anniversary in 2023 as a preeminent halogen-based specialty chemicals company.

www.iofina.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAXXSFFSLEFA
Date   Source Headline
5th Jun 20267:00 amRNSAgreement Signed for Additional Brine Water Supply
5th May 20267:00 amRNSNotice of AGM
30th Apr 20264:45 pmRNSHolding(s) in Company
30th Apr 202611:30 amRNSHolding(s) in Company
30th Apr 20267:00 amRNSFinal Results
16th Apr 20261:40 pmRNSHolding(s) in Company
15th Apr 20267:00 amRNSQ1 2026 Corporate Update
20th Mar 202612:25 pmRNSHolding(s) in Company
13th Jan 20267:00 amRNSQ4 2025 Corporate Update
6th Jan 20267:00 amRNSHolding(s) in Company
12th Dec 20257:00 amRNSDirectorate change
5th Dec 20257:00 amRNSAgreement with Western Midstream
12th Nov 20258:15 amRNSHolding(s) in Company
16th Oct 20257:00 amRNSQ3 2025 Update
3rd Oct 20253:32 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSInterim Results
4th Sep 20257:00 amRNSBusiness Update
17th Jul 20257:00 amRNSH1 2025 Update
9th Jul 20257:00 amRNSCapital Reduction
9th Jun 20255:00 pmRNSResult of AGM
14th May 20257:00 amRNSNotice of AGM and Proposed Capital Reduction
12th May 20257:00 amRNS-RInvestor Presentation
12th May 20257:00 amRNSFinal Results
25th Apr 20253:45 pmRNSHolding(s) in Company
17th Apr 20257:00 amRNSQ1 2025 Update
23rd Jan 20257:00 amRNSQ4 2024 Update
18th Dec 20244:45 pmRNSHolding(s) in Company
21st Oct 20247:00 amRNSHolding(s) in Company
18th Oct 20247:00 amRNSQ3 2024 Update
27th Sep 20247:00 amRNSIO#11 Update
20th Sep 20247:00 amRNSInterim Results
13th Sep 20247:00 amRNSIO#10 Iodine Plant Commissioned
16th Jul 20247:00 amRNSH1 Update
27th Jun 202411:04 amRNSHolding(s) in Company
25th Jun 20247:00 amRNSHolding(s) in Company
13th Jun 20241:00 pmRNSResult of AGM
29th May 20244:50 pmRNSLaunch of new website
15th May 20247:00 amRNSNotice of AGM and Resignation of Director
2nd May 20247:00 amRNSFinal Results
16th Apr 20247:00 amRNSQ1 2024 Corporate Update
17th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSQ4 2023 Corporate Update
30th Nov 20237:00 amRNSIO#9 Update
20th Oct 20237:00 amRNSSigned Agreement for IO#10 and Q3 2023 Update
11th Sep 20237:00 amRNSInterim Results
25th Aug 20235:00 pmRNSHolding(s) in Company
24th Jul 20235:00 pmRNSHolding(s) in Company
20th Jul 20237:00 amRNSH1 Update and Updated Loan Facilities
14th Jun 20232:00 pmRNSResult of AGM
14th Jun 20237:00 amRNSIO#9 Iodine Plant Operating

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.